BlackRock Institutional Trust’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$7.65M Buy
2,013,325
+140,100
+7% +$1.02M ﹤0.01% 2554
2016
Q3
$16.8M Buy
1,873,225
+191,106
+11% +$1.6M ﹤0.01% 2006
2016
Q2
$11.8M Buy
1,682,119
+117,212
+7% +$1.07M ﹤0.01% 2192
2016
Q1
$13.3M Buy
1,564,907
+114,653
+8% +$1.13M ﹤0.01% 2087
2015
Q4
$19M Buy
1,450,254
+43,376
+3% +$389K ﹤0.01% 1897
2015
Q3
$5.15M Buy
1,406,878
+204,732
+17% +$1M ﹤0.01% 2702
2015
Q2
$6.92M Buy
1,202,146
+60,328
+5% +$349K ﹤0.01% 2604
2015
Q1
$6.67M Buy
1,141,818
+376,238
+49% +$2.59M ﹤0.01% 2628
2014
Q4
$6M Buy
765,580
+197,495
+35% +$1.26M ﹤0.01% 2646
2014
Q3
$2.79M Sell
568,085
-391,653
-41% -$2.05M ﹤0.01% 2925
2014
Q2
$5.93M Sell
959,738
-209,809
-18% -$1.05M ﹤0.01% 2707
2014
Q1
$6.26M Sell
1,169,547
-1,285,570
-52% -$8.13M ﹤0.01% 2687
2013
Q4
$12.8M Buy
2,455,117
+1,821,803
+288% +$8.36M ﹤0.01% 2254
2013
Q3
$3.5M Buy
633,314
+106,565
+20% +$370K ﹤0.01% 2879
2013
Q2
$1.33M Buy
+526,749
New +$1.31M ﹤0.01% 3242

Other funds holding PACB

BlackRock Institutional Trust's PACB Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Pacific Biosciences (PACB) stake by 7.5% in Q4 2016, buying an estimated $1.02M and bringing the position to 2,013,325 shares worth $7.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2554.

BlackRock Institutional Trust first reported a position in PACB in Q2 2013 and has held it in 15 quarters since. The position peaked at $19M in Q4 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

  • BlackRock Institutional Trust held 2,013,325 shares of Pacific Biosciences worth $7.65M as of Q4 2016.
  • BlackRock Institutional Trust bought 140,100 Pacific Biosciences shares in Q4 2016, an estimated $1.02M.
  • Pacific Biosciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2554 holding.
  • BlackRock Institutional Trust first reported a position in Pacific Biosciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Pacific Biosciences position peaked at $19M in Q4 2015.
  • 115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.